Role of Sex on the Clinical Outcomes of Coronary Artery Diseases Treated with Drug-Eluting Stents

Authors

  • Prabjot K Batth Saba University School of Medicine, Brampton, Canada
  • Mohammed Alsabri Pediatrics Department, Brookdale Hospital, USA, EM and Critical Care consultant, DCH, Sanaa’, Yemen

DOI:

https://doi.org/10.3329/cardio.v14i2.58781

Keywords:

Coronary Artery Disease; Drug- Eluting Stents; Percutaneous Coronary Interventions; Sex Factors

Abstract

Background: With consideration of differing cardiac characteristics between women and men, such as coronary vessel sizes, this study was constructed to investigate if sex-based differences are present following drug-eluting stent implantation.

Methods: Using PubMed and MeSH search tags, published data analyzing the potential sex differences in clinical outcomes following drug-eluting stent implantation was collected.

Results: As compared to male patients, women had similar incidences of major adverse cardiac events and stent thrombosis at long-term follow-up despite being found to consistently have smaller vessels, higher incidences of advanced age, diabetes mellitus, and hypertension at hospital admission. At short-term follow-up, however, women had an increase of major adverse cardiac events as compared to men with complex lesions. Furthermore, height may play a role in clinical outcomes following treatment with a drug-eluting stent. Additionally, women may have superior healing responses with lower neointimal obstruction and lower maximum cross-sectional narrowing following drugeluting stent implantation.

Conclusions: When differing baseline characteristics were corrected for with multivariate analysis, drug-eluting stents demonstrate similar clinical outcomes in women and men at long-term follow-up.

Cardiovasc j 2022; 14(2): 157-167

Downloads

Download data is not yet available.
Abstract
109
PDF
82

Downloads

Published

2022-04-06

How to Cite

Batth, P. K., & Alsabri, M. . (2022). Role of Sex on the Clinical Outcomes of Coronary Artery Diseases Treated with Drug-Eluting Stents. Cardiovascular Journal, 14(2), 157–167. https://doi.org/10.3329/cardio.v14i2.58781

Issue

Section

Review Articles